Cardiac glycosides plus MAPK pathway inhibitors may preferentially kill melanoma cells because melanoma cells are addicted to MAPK pathway signalling4, 5, 6, 7, exhibit elevated ATP1A1 expression (Fig. 1e) and are more dependent on NHE function for maintenance of intracellular pH and survival57. This evidence concerns the gene SLC9C1 and melanoma.